Live-attenuated Chikungunya vaccine: a possible new era Publication: Journal Article Stephenson, Kathryn E. 2023. “Live-Attenuated Chikungunya Vaccine: A Possible New Era”. Lancet 401 (10394): 2090-91.
Novel chikungunya vaccine shows promise for durable protection Publication: Journal Article Stephenson, Kathryn E. 2022. “Novel Chikungunya Vaccine Shows Promise for Durable Protection”. Lancet Infectious Diseases 22 (9): 1259-61.
Passive transfer of Ad26.COV2.S-elicited IgG from humans attenuates SARS-CoV-2 disease in hamsters Publication: Journal Article Tostanoski, Lisa H., Abishek Chandrashekar, Shivani Patel-, -Kathryn E. Stephenson-, -Hanneke Schuitemaker, and Dan H. Barouch. 2022. “Passive Transfer of Ad26.COV2.S-Elicited IgG from Humans Attenuates SARS-CoV-2 Disease in Hamsters”. NPJ Vaccines 7 (1): 2.
Compassionate Use of Remdesivir in Pregnant Women With Severe Coronavirus Disease 2019 Publication: Journal Article Burwick, Richard M., Sigal Yawetz, Kathryn E. Stephenson-, -Rebecca Zash, and William R. Short. 2021. “Compassionate Use of Remdesivir in Pregnant Women With Severe Coronavirus Disease 2019”. Clinical Infectious Diseases 73 (11): e3996-e4004.
Safety and immunogenicity of a Zika purified inactivated virus vaccine given via standard, accelerated, or shortened schedules: a single-centre, double-blind, sequential-group, randomised, placebo-controlled, phase 1 trial Publication: Journal Article Stephenson, Kathryn E., Chen Sabrina Tan, Stephen R. Walsh-, -Kayvon Modjarrad, and Dan H. Barouch. 2020. “Safety and Immunogenicity of a Zika Purified Inactivated Virus Vaccine Given via Standard, Accelerated, or Shortened Schedules: A Single-Centre, Double-Blind, Sequential-Group, Randomised, Placebo-Controlled, Phase 1 Trial”. Lancet Infectious Diseases 20 (9): 1061-70.
Efficacy of Messenger RNA–1273 Against Severe Acute Respiratory Syndrome Coronavirus 2 Acquisition in Young Adults From March to December 2021 Publication: Journal Article Stephenson, Kathryn E., Jasmine R. Marcelin, Audrey E. Pettifor-, -Lawrence Corey, and James G. Kublin. 2023. “Efficacy of Messenger RNA–1273 Against Severe Acute Respiratory Syndrome Coronavirus 2 Acquisition in Young Adults From March to December 2021”. Open Forum Infectious Diseases 10 (11): ofad511.
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Household Transmission during the Omicron Era in Massachusetts: A Prospective, Case-Ascertained Study using Genomic Epidemiology Publication: Journal Article Banga, Jaspreet, Taylor Brock-Fisher, Brittany A. Petros-, -Pardis C. Sabeti, and Kathryn E. Stephenson. 2024. “Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Household Transmission During the Omicron Era in Massachusetts: A Prospective, Case-Ascertained Study Using Genomic Epidemiology”. MedRxiv.